Tandem Diabetes Care, Inc. (TNDM) Social Stream
Tandem Diabetes Care Inc (TNDM) Price Targets From Analysts
Use the tables below to see what analysts covering Tandem Diabetes Care Inc think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-08 | 10 | $154 | $90 | $127.3 | $119.34 | 6.67% |
| 2021-12-06 | 9 | $154 | $90 | $127 | $119.34 | 6.42% |
| 2021-12-19 | 7 | $170 | $90 | $133.5 | $119.34 | 11.87% |
| 2022-02-23 | 8 | $170 | $90 | $136.444 | $119.34 | 14.33% |
| 2022-02-24 | 8 | $170 | $90 | $135.375 | $119.34 | 13.44% |
| 2022-03-01 | 7 | $170 | $90 | $134.777 | $119.34 | 12.94% |
The Trend in the Analyst Price Target
Over the past 46 weeks, TNDM's average price target has gone up $8.45.
TNDM reports an average of 11.46% for its upside potential over the past 46 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-08-14 | 15 | 165 | 90 | 132.750 | 107.24 | 23.79% |
| 2021-11-08 | 10 | 154 | 90 | 127.300 | 135.67 | -6.17% |
| 2021-11-08 | 9 | 154 | 90 | 127.300 | 135.67 | -6.17% |
| 2021-12-06 | 8 | 154 | 90 | 127.000 | 131.01 | -3.06% |
| 2022-02-24 | 6 | 170 | 90 | 135.375 | 110.20 | 22.84% |
TNDM Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.29 | 3 | 1 | 2 | 1 | 1 | 7 |
The Trend in the Broker Recommendations
Over the past 30 weeks, TNDM's average broker recommendation rating worsened by 0.05.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- To contextualize these metrics, consider that out of all US stocks, Tandem Diabetes Care Inc's average analyst price target is higher than 1046.8% of them.
- TNDM has a higher upside potential (average analyst target price relative to current price) than 149.96% of Healthcare stocks.
- To contextualize these metrics, consider that out of Medical Equipment stocks, Tandem Diabetes Care Inc's variance in analysts' estimates is lower than -932.5% of them.
- In terms of how Tandem Diabetes Care Inc fares relative to Healthcare stocks, note that its number of analysts covering the stock is higher than 827.24% of that group.
Stocks similar to Tandem Diabetes Care Inc in the Medical Equipment industry regarding analyst recommendations and price targets are SWAV, SKIN, and SILK.
Is TNDM a Buy, Hold or Sell? See the POWR Ratings now!